FranΓ§ais| Metric | CVS Health | UnitedHealth Group | Edge |
|---|---|---|---|
| Price | $92.92 | $395 | |
| Median target (12m) | $112 (+20%) | $478 (+21%) | |
| Analyst reliability (1y) | 42% | 48% | π΅ UNH |
| Avg gain / call (1y) | +8% | +11% | |
| P/E | 24.8 | 25.8 | π’ CVS |
| $1000 invested (10y ago) | $1,071 | $3,533 | π΅ UNH |
| Year | CVS | UNH | Winner |
|---|---|---|---|
| 2026 | +39% | +26% | π’ CVS |
| 2025 | +32% | -35% | π’ CVS |
| 2024 | -24% | -4% | π΅ UNH |
| 2023 | -16% | -1% | π΅ UNH |
| 2022 | -17% | +6% | π΅ UNH |
| 2021 | +49% | +43% | π’ CVS |
| 2020 | +6% | +19% | π΅ UNH |
| 2019 | +3% | +18% | π΅ UNH |
| 2018 | -17% | +13% | π΅ UNH |
| 2017 | -0% | +38% | π΅ UNH |
| 2016 | -18% | +36% | π΅ UNH |
Over ~10 years, CVS Health returned $1,071 on $1000 vs $3,533 for UnitedHealth Group, and UnitedHealth Group has better analyst reliability. Not advice: also check valuation (P/E) and your horizon.
Over ~10 years, UnitedHealth Group wins ($1,071 vs $3,533 on $1000 invested, price return excluding dividends).
On P/E, CVS Health is cheaper (24.8 vs 25.8). A lower P/E isn't always a better deal (growth matters).
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Past price performance (excluding dividends). Data: Yahoo Finance.